Patterns of long-term survivorship following bevacizumab treatment for recurrent glioma: a case series

Patterns of long-term survivorship following bevacizumab treatment for recurrent glioma: a case series

Aim: Long-term survivors (LTS) after glioma recurrence while on bevacizumab (Bev) therapy are rarely reported in the current literature. The purpose of this case series is to confirm the existence of and describe a large cohort of recurrent glioma LTS treated with Bev (Bev-LTS). Patients & metho...

Description complète

Détails bibliographiques
Auteurs principaux: Liang Yen Liu, Matthew S Ji, Nhung T Nguyen, Frances E Chow, Donna M Molaie, Sean T Pianka, Richard M Green, Linda M Liau, Benjamin M Ellingson, Phioanh L Nghiemphu, Timothy F Cloughesy, Albert Lai
Format: Article
Langue:English
Publié: Taylor & Francis Group 2019-06-01
Collection:CNS Oncology
Sujets:
bevacizumab
glioblastoma
glioma
long term
progression
recurrence
Accès en ligne:https://www.futuremedicine.com/doi/10.2217/cns-2019-0007

Documents similaires

Documents similaires